 Collegium Pharmaceutical, Inc. NASDAQ:COLL Q2 2022 Results Conference Call August 4, 2022 4:30 PM ET Company Participants Alex Dasalla - Head, IR Joseph Ciaffoni - CEO Colleen Tupper - CFO Scott Dreyer - CCO Conference Call Participants Greg Fraser - Truist David Amsellem - Piper Sandler Serge Belanger - Needham Company Tim Lugo - William Blair Operator Greetings, and welcome to the Collegium Pharmaceutical Second Quarter 2022 Earnings Call. Operator Instructions Please note that this conference is being recorded. 